Article

Preschoolers' test scores improved with prescription glasses

According to a new study, preschoolers' test scores improved within 6 weeks of consistently wearing prescription glasses.

San Diego-According to a new study, preschoolers' test scores improved within 6 weeks of consistently wearing prescription glasses.

"It has been theorized that when young children have early vision problems that are undiagnosed and uncorrected, their development and performance in school are impacted," said Stuart I. Brown, chairman of ophthalmology and director of the Shiley Eye Center University of California, San Diego, School of Medicine, in a prepared statement. "This study shows that children with vision impairment do perform below the norm in visual-motor coordination tests, and that they catch up quickly once they are given corrective [lenses]."

About half of the 70 participants, aged 3 to 5 years, had normal vision and half were diagnosed with ametropia. Children took two standardized tests that relate directly to future school performance: the Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI) and the Wechsler Preschool and Primary Scale of Intelligence-revised (WPPSI-R).

The vision-impaired children scored significantly lower on both tests, however, once they were given glasses and monitored by their families to wear their glasses consistently, the scores on the VMI were at the same level as children with normal vision. The WPPSI-R scores did not show dramatic improvement according to the study, published in the February issue of the Archives of Ophthalmology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.